Poly Medicure Ltd. (BSE: 531768) is a New Delhi, Delhi-based company in the Medical Consumables industry. With a market capitalisation of ₹17,162 Cr, it ranks #411 by market cap among the 6,197 Indian listed companies on FinBizNet, and #1 of 14 in Medical Consumables. At ₹1,675.00 (as of 19 Nov 2026), the share price is 17.2% below its 52-week high of ₹2,024.00 and 41.7% above its 52-week low of ₹1,182.00. The share price is down 14.5% over one year and down 5.4% over three months.
| Current Price | ₹1,675.00 |
|---|---|
| Market Cap | ₹17,162 Cr |
| BSE Code | 531768 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies |
| Sub-Industry | Health Care Supplies > Medical Consumables |
| P/E Ratio | 53.3 |
| Return on Equity | 10.84% |
| Return on Assets | 5.78% |
| 52-Week Range | ₹1,182.00 – ₹2,024.00 |
| 1-Year Price Change | -14.5% |
| 3-Month Price Change | -5.4% |
| Beta (1Y) | 0.05 |
| Dividend Yield | 0.21% |
| Headquarters | New Delhi, Delhi |
| Website | www.polymedicure.com |
| Revenue | ₹581 Cr |
|---|---|
| Net Profit | ₹95 Cr |
| Net Margin | 16.4% |
| EPS (Basic) | ₹9.38 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Poly Medicure Ltd. reported revenue of ₹581 Cr in Q2 FY27, up 30.8% from ₹444 Cr in Q2 FY26 and up 10.5% from ₹525 Cr in Q1 FY27. It posted a net profit of ₹95 Cr for the quarter, against a net profit of ₹91 Cr in Q2 FY26 (up 4.7%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹403 Cr (Q1 FY26) to ₹581 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹581 Cr | ₹95 Cr | 16.4% |
| Q1 FY27 | ₹525 Cr | ₹84 Cr | 15.9% |
| Q4 FY26 | ₹535 Cr | ₹63 Cr | 11.8% |
| Q3 FY26 | ₹494 Cr | ₹69 Cr | 14.0% |
| Q2 FY26 | ₹444 Cr | ₹91 Cr | 20.5% |
| Q1 FY26 | ₹403 Cr | ₹92 Cr | 22.8% |
| Q4 FY25 | ₹441 Cr | ₹90 Cr | 20.3% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 62.42% of Poly Medicure Ltd.'s shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 49.5% of traded volume across 18 NSE sessions (26 Oct 2026 – 19 Nov 2026).
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access
1. Medical Devices-This segment engages in the manufacture and sale of medical devices. It offers IV based infusion therapy devices, central venous access catheters, urine collection bags, and anesthesia devices.
1. Manufacture and Sale of Medical Devices-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Poly Medicure Ltd. | ₹17,162 Cr | 53.3 | 10.84% | ₹581 Cr | -14.5% |
| Sahajanand Medical Technologies | ₹4,899 Cr | 77.9 | — | ₹373 Cr | — |
| Q-Line Biotech Limited | ₹1,280 Cr | 15.7 | 22.63% | — | — |
| Laxmi Dental Limited | ₹1,128 Cr | 39.3 | 12.77% | ₹80 Cr | -38.2% |
| Prevest Denpro Ltd | ₹502 Cr | 24.6 | 17.79% | — | -22.6% |
| Choksi Imaging Ltd. | ₹119 Cr | 22.3 | 13.51% | — | +94.0% |
| GSM Foils Limited | ₹72 Cr | 3.9 | 37.54% | ₹97 Cr | -78.3% |
| Mohini Health & Hygiene Ltd | ₹51 Cr | n/m | -17.18% | — | -41.2% |
| KMS Medisurgi Limited | ₹46 Cr | 188.4 | — | — | +4.7% |
Listed by market capitalisation. Ratios are shown for context only.
Poly Medicure Ltd. is trading at ₹1,675.00, with a market capitalisation of ₹17,162 Cr.
Poly Medicure Ltd. operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Supplies > Medical Consumables).
Poly Medicure Ltd. has a P/E of 53.3 and a return on equity of 10.84%.
Poly Medicure Ltd. is listed on the BSE under the scrip code 531768.
Poly Medicure Ltd.'s share price is down 14.5% over one year and down 5.4% over three months. Its 52-week range is ₹1,182.00 to ₹2,024.00.
In Q2 FY27, Poly Medicure Ltd. reported revenue of ₹581 Cr and net profit of ₹95 Cr, with basic EPS of ₹9.38 (consolidated, parsed from the company's exchange filing).
Poly Medicure Ltd. reported revenue of ₹581 Cr in Q2 FY27, up 30.8% from ₹444 Cr in Q2 FY26 and up 10.5% from ₹525 Cr in Q1 FY27.
Promoters held 62.42% of Poly Medicure Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.
Data as of 19 Nov 2026. Descriptive market data only — not investment advice.